Astellas Pharma Inc.

Earnings Per Share Growth (%)45.96%
Cost of Goods Sold (US$ Millions)$2,788
Current Liabilities (US$ Millions)$3,434
Total Assets (US$ Millions)$7,456
Long Term Debt$0
Return on Equity14.70%
Revenue (US$ Millions)$11,403
Total Company Assets$14,947
Revenue Growth (%)10.06%
Net Income (US$ Millions)$1,609
Earnings Per Share (US$)$45.96
Total Equity (US$ Millions)$10,460
Profit Margin (%)14.11%
Debt To Equity Ratio (%)0.00%
Inventory Turnover$1,343